Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

644 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Willerson JT, Chan R, Samuels R, Ilson B, Granett J. Topol EJ, et al. Among authors: shuaib a. Am Heart J. 2000 Jun;139(6):927-33. doi: 10.1067/mhj.2000.105107. Am Heart J. 2000. PMID: 10827369 Clinical Trial.
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Topol EJ, Easton D, Harrington RA, Amarenco P, Califf RM, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Granett J, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Sigmon K, Pieper K, Vallee M, Willerson JT; Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators. Topol EJ, et al. Among authors: shuaib a. Circulation. 2003 Jul 29;108(4):399-406. doi: 10.1161/01.CIR.0000084501.48570.F6. Epub 2003 Jul 21. Circulation. 2003. PMID: 12874182 Clinical Trial.
Cervical arterial dissection: time for a therapeutic trial?
Beletsky V, Nadareishvili Z, Lynch J, Shuaib A, Woolfenden A, Norris JW; Canadian Stroke Consortium. Beletsky V, et al. Among authors: shuaib a. Stroke. 2003 Dec;34(12):2856-60. doi: 10.1161/01.STR.0000098649.39767.BC. Epub 2003 Nov 6. Stroke. 2003. PMID: 14605328 Clinical Trial.
Endothelial progenitor cells during cerebrovascular disease.
Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K. Ghani U, et al. Among authors: shuaib u, shuaib a. Stroke. 2005 Jan;36(1):151-3. doi: 10.1161/01.STR.0000149944.15406.16. Epub 2004 Dec 2. Stroke. 2005. PMID: 15576657
NXY-059 for acute ischemic stroke.
Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW; Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. Lees KR, et al. Among authors: shuaib a. N Engl J Med. 2006 Feb 9;354(6):588-600. doi: 10.1056/NEJMoa052980. N Engl J Med. 2006. PMID: 16467546 Free article. Clinical Trial.
Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.
Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, Calleja S, Garami Z, Khan K, Akhtar N, O'Rourke F, Shuaib A, Demchuk AM, Alexandrov AV; CLOTBUST Investigators. Saqqur M, et al. Among authors: shuaib a. Stroke. 2007 Jan;38(1):69-74. doi: 10.1161/01.STR.0000251800.01964.f6. Epub 2006 Nov 30. Stroke. 2007. PMID: 17138949
644 results